| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|---|---|---|
| 11.30 | 0.10 (+0.85%) | 2.25 - 12.50 | 23.0 thousand (Below Avg) |
Market data as of 9:56AM 05/21/13. Quotes are delayed by at least 15 min.
| Open | 11.20 |
|---|---|
| Previous Close | 11.20 |
| Day's Range | 11.06 - 11.35 |
| Market Cap | 354.9M |
| Avg Volume (10 Day) | 530.0K |
| Price/Earnings (Trailing 12 Mo.) | -- |
| Earnings Per Share (Trailing 12 Mo.) | -0.12 |
| Dividend Yield | No Dividend |


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Performed well consistently? | Fail |
|---|---|
| Avoids excess debt? | Fail |
| Converting sales to profits? | Fail |
| Shareholder's money handled rationally? | Neutral |
| Increased shareholder value? | Neutral |
| Consistently increased owner earnings? | Fail |
| Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
| Pays a cash dividend? | Fail |
|---|---|
| Room to increase dividends? | Fail |
| Increased earnings over time? | Fail |
| Borrows within reasonable limits? | Pass |
| Stock is undervalued? | Fail |
| Have investors caught on? | Fail |
| Has support of institutional investors? | Pass |
| Has sufficient liquidity? | Pass |
AMRI CFO to Present at the UBS Global Healthcare Conference
PR Newswire - Wednesday 05/15/2013 8:00 AM ET
AMRI Announces First Quarter 2013 Results and Raises EPS Guidance for the Year
PR Newswire - Tuesday 05/07/2013 8:00 AM ET
AMRI to Announce First Quarter Results
PR Newswire - Wednesday 04/24/2013 8:00 AM ET
AMRI and Ono Broaden SMARTSOURCING™ Collaboration
PR Newswire - Tuesday 04/23/2013 3:00 PM ET
AMRI CEO to Present at the 12th Annual Needham Healthcare Conference
PR Newswire - Tuesday 04/23/2013 8:00 AM ET
| AMRI | Industry Range | |
|---|---|---|
| Revenue Growth (1yr) | 9.17% | |
| Net Income Growth (1yr) | -- | |
| Total Debt/Equity | 0.04 | |
| LT Debt/Equity | 0.04 | |
| Earnings Yield | -- | |
| Price/Sales | 1.55 |
| Company | Last | Change |
|---|---|---|
| Osiris Therapeutics Inc | 10.85 | +1.40% |
| GTX Inc | 5.89 | +5.18% |
| XOMA Corp | 4.27 | +2.64% |
| 3SBio Inc | 16.56 | -0.12% |
| Enanta Pharmaceuticals Inc | 20.85 | +0.72% |
Data is delayed by at least 15 min.